Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study.
Bizzaro N, Bartoloni E, Morozzi G, Manganelli S, Riccieri V, Sabatini P, Filippini M, Tampoia M, Afeltra A, Sebastiani G, Alpini C, Bini V, Bistoni O, Alunno A, Gerli R; Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA Group). Bizzaro N, et al. Among authors: riccieri v. Arthritis Res Ther. 2013 Jan 22;15(1):R16. doi: 10.1186/ar4148. Arthritis Res Ther. 2013. PMID: 23339296 Free PMC article.
Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement.
Bombardieri M, Alessandri C, Labbadia G, Iannuccelli C, Carlucci F, Riccieri V, Paoletti V, Valesini G. Bombardieri M, et al. Among authors: riccieri v. Arthritis Res Ther. 2004;6(2):R137-41. doi: 10.1186/ar1041. Epub 2004 Jan 29. Arthritis Res Ther. 2004. PMID: 15059277 Free PMC article.
Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA).
Tincani A, Morozzi G, Afeltra A, Alessandri C, Allegri F, Bistoni O, Bizzaro N, Caccavo D, Galeazzi M, Gerli R, Giovannelli L, Longobardo G, Lotzniker M, Malacarne F, Migliorini P, Parodi A, Pregnolato F, Radice A, Riccieri V, Ruffelli M, Sinico RA, Tozzoli R, Villalta D, Marcolongo R, Meroni P; Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA). Tincani A, et al. Among authors: riccieri v. Clin Exp Rheumatol. 2007 Mar-Apr;25(2):268-74. Clin Exp Rheumatol. 2007. PMID: 17543152
Evaluation of current methods for the measurement of serum anti double-stranded DNA antibodies.
Ghirardello A, Villalta D, Morozzi G, Afeltra A, Galeazzi M, Gerli R, Mathieu A, Meroni PL, Migliorini P, Radice A, Riccieri V, Ruffatti A, Sebastiani GD, Tincani A, Doria A; FIRMA group. Ghirardello A, et al. Among authors: riccieri v. Ann N Y Acad Sci. 2007 Aug;1109:401-6. doi: 10.1196/annals.1398.045. Ann N Y Acad Sci. 2007. PMID: 17785328 Review.
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
Costa S, Mondini M, Caneparo V, Afeltra A, Airò P, Bellisai F, Faggioli P, Gerli R, Lotzniker M, Meroni PL, Morozzi G, Radice A, Riccieri V, Scarsi M, Sebastiani GD, Sinico RA, Tincani A, Gariglio M, Landolfo S. Costa S, et al. Among authors: riccieri v. Rheumatology (Oxford). 2011 Apr;50(4):674-81. doi: 10.1093/rheumatology/keq372. Epub 2010 Dec 6. Rheumatology (Oxford). 2011. PMID: 21134960
Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study.
Ghirardello A, Villalta D, Morozzi G, Afeltra A, Galeazzi M, Gerli R, Mathieu A, Meroni PL, Pregnolato F, Migliorini P, Radice A, Riccieri V, Ruffatti A, Sebastiani GD, Sinico RA, Tincani A, Doria A; Forum Interdisciplinare per la Ricerca sulle Malattie Autoimmuni(FIRMA) study group. Ghirardello A, et al. Among authors: riccieri v. Clin Exp Rheumatol. 2011 Jan-Feb;29(1):50-6. Epub 2011 Feb 23. Clin Exp Rheumatol. 2011. PMID: 21345292
Multicentric evaluation of a second generation assay to detect antiviral citrullinated peptide antibodies: a collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni.
Bizzaro N, Allegri F, Alpini C, Doria A, Gerli R, Lotzniker M, Mathieu A, Morozzi G, Bellisai F, Riccieri V, Tampoia M, Migliorini P. Bizzaro N, et al. Among authors: riccieri v. J Clin Pathol. 2011 Dec;64(12):1139-41. doi: 10.1136/jclinpath-2011-200308. Epub 2011 Sep 30. J Clin Pathol. 2011. PMID: 21965824
Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G, Doria A, Mathieu A, Lotzniker M, Allegri F, Riccieri V, Alpini C, Gabrielli A, Tampoia M, Gerli R; Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA) investigators. Bartoloni E, et al. Among authors: riccieri v. Autoimmun Rev. 2012 Sep;11(11):815-20. doi: 10.1016/j.autrev.2012.02.015. Epub 2012 Feb 27. Autoimmun Rev. 2012. PMID: 22394488
Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases.
Pecani A, Alessandri C, Spinelli FR, Priori R, Riccieri V, Di Franco M, Ceccarelli F, Colasanti T, Pendolino M, Mancini R, Truglia S, Barbati C, Vomero M, Sabatinelli D, Morello F, Valesini G, Conti F. Pecani A, et al. Among authors: riccieri v. Arthritis Res Ther. 2016 Nov 25;18(1):276. doi: 10.1186/s13075-016-1173-0. Arthritis Res Ther. 2016. PMID: 27887639 Free PMC article.
247 results